LTIP903A - Preparation process of solid pharmaceutical forms and such forms - Google Patents

Preparation process of solid pharmaceutical forms and such forms

Info

Publication number
LTIP903A
LTIP903A LTIP903A LTIP903A LTIP903A LT IP903 A LTIP903 A LT IP903A LT IP903 A LTIP903 A LT IP903A LT IP903 A LTIP903 A LT IP903A LT IP903 A LTIP903 A LT IP903A
Authority
LT
Lithuania
Prior art keywords
forms
solid pharmaceutical
preparation process
ebselen
pharmaceutical forms
Prior art date
Application number
LTIP903A
Inventor
Juergen Seidel
Axel Roemer
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of LTIP903A publication Critical patent/LTIP903A/en
Publication of LT3669B publication Critical patent/LT3669B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Solid pharmaceutical compositions containing 2-phenyl-1,2-benzisoselenazol-3(2H)-one (EBSELEN) with high bioavailability thereof contain EBSELEN in the form of micronised crystals of EBSELEN and are prepared as described.
LTIP903A 1987-06-20 1993-08-30 Preparation process of solid pharmaceutical forms and such forms LT3669B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (en) 1987-06-20 1987-06-20 MEDICINAL PREPARATIONS WITH MICRONIZED EBSELEN CRYSTALS

Publications (2)

Publication Number Publication Date
LTIP903A true LTIP903A (en) 1995-03-27
LT3669B LT3669B (en) 1996-01-25

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP903A LT3669B (en) 1987-06-20 1993-08-30 Preparation process of solid pharmaceutical forms and such forms

Country Status (25)

Country Link
US (1) US5021242A (en)
EP (1) EP0296389B1 (en)
JP (1) JPH0713016B2 (en)
KR (1) KR970005322B1 (en)
AT (1) ATE69165T1 (en)
AU (1) AU603454B2 (en)
CA (1) CA1310906C (en)
DD (1) DD271056A5 (en)
DE (2) DE3720493A1 (en)
DK (1) DK173628B1 (en)
ES (1) ES2041736T3 (en)
FI (1) FI88256C (en)
GE (1) GEP19960342B (en)
GR (1) GR3003084T3 (en)
HU (1) HU200096B (en)
IE (1) IE63512B1 (en)
LT (1) LT3669B (en)
LV (1) LV10381B (en)
MX (1) MX169170B (en)
NO (1) NO175133C (en)
NZ (1) NZ225066A (en)
PT (1) PT87767B (en)
RU (1) RU1834657C (en)
UA (1) UA12648A (en)
ZA (1) ZA884025B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (en) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa NOVEL SOLID PHARMACEUTICAL COMPOSITIONS BASED ON 1,4-SUBSTITUTED LAPIPERIDINE DERIVATIVES.
JP2553434B2 (en) * 1992-04-28 1996-11-13 第一製薬株式会社 Granular formulation
US6335036B1 (en) * 1993-10-27 2002-01-01 Daiichi Pharmaceutical Co., Ltd. Granular pharmaceutical preparation of ebselen
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
DK0812195T3 (en) * 1995-02-28 2003-03-03 Aventis Pharma Inc Pharmaceutical composition for piperidinoalkanol compounds
ATE238773T1 (en) * 1997-08-26 2003-05-15 Aventis Pharma Inc MEDICINAL PRODUCTS FOR THE COMBINATION OF PIPERIDINOALKANOL-DECONGESTIVE
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
EP1174423A4 (en) 1999-03-31 2008-03-19 Arne Holmgren Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
CN1753867A (en) * 2003-02-24 2006-03-29 马林克罗特公司 The method for preparing benzhydryl thioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008148064A1 (en) * 2007-05-23 2008-12-04 Sunesis Pharmaceuticals, Inc. Weight loss treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
EP4536191A1 (en) * 2022-06-06 2025-04-16 Sound Pharmaceuticals Incorporated Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (en) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmaceutical preparations containing 2-phenyl-1,2-benzisoselenazol-3 (2H) -one
DE3407511A1 (en) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln BENZISOSELENAZOLTHIONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3616923A1 (en) * 1986-05-20 1987-11-26 Nattermann A & Cie NEW PHARMACEUTICAL USE OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ON
DE3620674A1 (en) * 1986-06-20 1987-12-23 Nattermann A & Cie Ointment for the treatment of skin diseases

Also Published As

Publication number Publication date
ATE69165T1 (en) 1991-11-15
RU1834657C (en) 1993-08-15
ES2041736T3 (en) 1996-07-16
GEP19960342B (en) 1996-02-20
NO175133B (en) 1994-05-30
UA12648A (en) 1997-02-28
LT3669B (en) 1996-01-25
DD271056A5 (en) 1989-08-23
MX169170B (en) 1993-06-23
DK173628B1 (en) 2001-05-07
DK333388D0 (en) 1988-06-17
JPH0713016B2 (en) 1995-02-15
ZA884025B (en) 1988-12-20
FI88256B (en) 1993-01-15
IE881628L (en) 1988-12-20
EP0296389A1 (en) 1988-12-28
EP0296389B1 (en) 1991-11-06
PT87767A (en) 1989-05-31
IE63512B1 (en) 1995-05-03
LV10381B (en) 1995-06-20
DK333388A (en) 1988-12-21
FI882912L (en) 1988-12-21
GR3003084T3 (en) 1993-02-17
LV10381A (en) 1995-02-20
KR890000084A (en) 1989-03-11
CA1310906C (en) 1992-12-01
JPH01100125A (en) 1989-04-18
DE3866033D1 (en) 1991-12-12
NO882615L (en) 1988-12-21
KR970005322B1 (en) 1997-04-15
DE3720493A1 (en) 1989-01-26
HU200096B (en) 1990-04-28
NO882615D0 (en) 1988-06-14
PT87767B (en) 1992-10-30
FI882912A0 (en) 1988-06-17
NO175133C (en) 1994-09-07
NZ225066A (en) 1990-07-26
HUT50037A (en) 1989-12-28
AU603454B2 (en) 1990-11-15
FI88256C (en) 1993-04-26
AU1811688A (en) 1988-12-22
US5021242A (en) 1991-06-04

Similar Documents

Publication Publication Date Title
LTIP903A (en) Preparation process of solid pharmaceutical forms and such forms
GR3004925T3 (en)
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
PT86819A (en) PROCESS FOR THE PREPARATION OF NOVEL INSULIN DERIVATIVES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
EP0302793A3 (en) Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
AU583166B2 (en) Oral garlic preparations and process for preparing same
DE2961394D1 (en) 1-oxo-1h-pyrimido (6,1-b) benzothiazole derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3068585D1 (en) Derivatives of 3,4,5-trihydroxypiperidine, processes for their preparation, and their use as medicines and in animal food
HUT47600A (en) Process for production of encephalinase glykopeptids, amin acid derivatives with hindering effect and medical compositions containing them
PT81954A (en) Process for the preparation of pharmaceutical compositions containing 9,10-dihydro alkalloids of ergot
IL60025A (en) Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
AU597090B2 (en) 2-acyloxypropylamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
PT76870A (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
IL57939A (en) Pharmaceutical compositions containing n-substituted aziridine-2-carboxylic acid derivatives,some such novel compounds and processes for the preparation of said n-substituted aziridine-2-carboxylic acid derivatives
HUT49807A (en) Process for production of medical compositions and the active substance
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
PT84466A (en) Process for preparing aryl-azolylmethyl-benzocycloalkene derivatives and of pharmaceutical and fungicidal compositions containing the same
PT86297A (en) Process for preparing aryloxybenzeneacetic acid derivatives and of pharmaceutical compositions containing the same
PT71211A (en) Process for the preparation of 3-substituted-tetrahydropyrrolo/1,2-a/pyrimidines and pharmaceutical compositions containing the same and new 3-substituted-tetrahydro-pyrrolo/1,2-a/ pyrimidines
PT77946A (en) Process for preparing substituted carboxi-thiazolo<3,2-a>pyrimidine derivatives and of pharmaceutical compositions containing the same
PT71212A (en) Process for the preparation of 3-substituted hexahydro-pyrimido/1,2-a/azepines and pharmaceutical compositions containing the same and new 3-substituted-hexahydro-pyrimido/1,2-a/azepines

Legal Events

Date Code Title Description
MK9A Expiry of a patent

Effective date: 20130830